User:Joflaher/sandbox
C-type lectin domain family 1 member B (i.e., CLEC-1b), also termed C-type lectin-like receptor 2 (i.e., CLEC-2), CLEC2, CLEC2B, PRO1384, QDED721, C-type lectin domain family 1 member B (i.e., CLEC1B), activation-induced C-type lectin (i.e., AICL) and 1810061I13Rik is a cell surface receptor protein that in humans is encoded by the CLEC1B gene. The human CLEC1B gene is located on the short (i.e., "p")-arm of chromosome 12 at region 1, band 3, sub-band 1 to sub-band 2 (position notated as 12p13.31-p13.2).<https://www.ncbi.nlm.nih.gov/gene/387836> Most of the recent literature terms the C-type lectin domain family 1 member B as CLEC-2.[1][2][3][4][5][6] Here, CLEC-2 is used for the CLEC-1B protein, CLEC-1b is used for the human CLEC-1b gene, and Clec-2 for the animal CLEC-1b gene.
CLEC-2 is a member of the broad family of pattern recognition receptors (i.e., PRRs). Vertebrate PRRs can be classified into five types based on their structural similarities: toll-like receptors, NOD-like receptors, RIG-I-like receptors, absent in melanoma 2 receptors, and CLEC-2. receptors.[7][8] The C-type lectin group consist of more than 1,000 proteins that are subdivided into 17 subgroups. All members of this family possess one or more C-type lectin-like domains (i.e., protein domains that have a characteristic loop-in-a-loop structure stabilized by two highly conserved disulfide bridges located at the bases of the loops[9]).[10]
CLEC-2 was initially defined as a receptor for podoplanin, i.e., PDPN, but in 2022 was found to be a receptor for C-type lectin domain family 7 member A, i.e., dectin-1.[8][11]
Natural killer (NK) cells express multiple calcium-dependent (C-type) lectin-like receptors, such as CD94 (KLRD1; MIM 602894) and NKG2D (KLRC4; MIM 602893), that interact with major histocompatibility complex class I molecules and either inhibit or activate cytotoxicity and cytokine secretion. CLEC2 is a C-type lectin-like receptor expressed in myeloid cells and NK cells.[supplied by OMIM][3]
References
[edit]- ^ Colonna M, Samaridis J, Angman L (Mar 2000). "Molecular characterization of two novel C-type lectin-like receptors, one of which is selectively expressed in human dendritic cells". Eur J Immunol. 30 (2): 697–704. doi:10.1002/1521-4141(200002)30:2<697::AID-IMMU697>3.0.CO;2-M. PMID 10671229.
- ^ Sobanov Y, Bernreiter A, Derdak S, Mechtcheriakova D, Schweighofer B, Duchler M, Kalthoff F, Hofer E (Dec 2001). "A novel cluster of lectin-like receptor genes expressed in monocytic, dendritic and endothelial cells maps close to the NK receptor genes in the human NK gene complex". Eur J Immunol. 31 (12): 3493–503. doi:10.1002/1521-4141(200112)31:12<3493::AID-IMMU3493>3.0.CO;2-9. PMID 11745369. S2CID 42415487.
- ^ a b "Entrez Gene: CLEC1B C-type lectin domain family 1, member B".
- ^ Meng D, Luo M, Liu B (2021). "The Role of CLEC-2 and Its Ligands in Thromboinflammation". Frontiers in Immunology. 12: 688643. doi:10.3389/fimmu.2021.688643. PMC 8220156. PMID 34177942.
- ^ Li X, Tao X, Ding X (August 2022). "An integrative analysis to reveal that CLEC2B and ferroptosis may bridge the gap between psoriatic arthritis and cancer development". Scientific Reports. 12 (1): 14653. doi:10.1038/s41598-022-19135-2. PMC 9420124. PMID 36030279.
- ^ Jing Q, Yuan C, Zhou C, Jin W, Wang A, Wu Y, Shang W, Zhang G, Ke X, Du J, Li Y, Shao F (June 2023). "Comprehensive analysis identifies CLEC1B as a potential prognostic biomarker in hepatocellular carcinoma". Cancer Cell International. 23 (1): 113. doi:10.1186/s12935-023-02939-1. PMC 10262401. PMID 37308868.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Li D, Wu M (August 2021). "Pattern recognition receptors in health and diseases". Signal Transduction and Targeted Therapy. 6 (1): 291. doi:10.1038/s41392-021-00687-0. PMC 8333067. PMID 34344870.
- ^ a b Sun L, Wang Z, Liu Z, Mu G, Cui Y, Xiang Q (March 2024). "C-type lectin-like receptor 2: roles and drug target". Thrombosis Journal. 22 (1): 27. doi:10.1186/s12959-024-00594-8. PMC 10949654. PMID 38504248.
{{cite journal}}: CS1 maint: unflagged free DOI (link) - ^ Zelensky AN, Gready JE (December 2005). "The C-type lectin-like domain superfamily". The FEBS Journal. 272 (24): 6179–217. doi:10.1111/j.1742-4658.2005.05031.x. PMID 16336259.
- ^ Reis e Sousa C, Yamasaki S, Brown GD (April 2024). "Myeloid C-type lectin receptors in innate immune recognition". Immunity. 57 (4): 700–717. doi:10.1016/j.immuni.2024.03.005. PMID 38599166.
- ^ Haji S, Ito T, Guenther C, Nakano M, Shimizu T, Mori D, Chiba Y, Tanaka M, Mishra SK, Willment JA, Brown GD, Nagae M, Yamasaki S (December 2022). "Human Dectin-1 is O-glycosylated and serves as a ligand for C-type lectin receptor CLEC-2". eLife. 11. doi:10.7554/eLife.83037. PMC 9788829. PMID 36479973.
{{cite journal}}: CS1 maint: unflagged free DOI (link)
External links
[edit]- Human CLEC1B genome location and CLEC1B gene details page in the UCSC Genome Browser.
- Human CLEC2B genome location and CLEC2B gene details page in the UCSC Genome Browser.
Further reading
[edit]- Strausberg RL, Feingold EA, Grouse LH, et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. Bibcode:2002PNAS...9916899M. doi:10.1073/pnas.242603899. PMC 139241. PMID 12477932.
- Clark HF, Gurney AL, Abaya E, et al. (2003). "The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment". Genome Res. 13 (10): 2265–70. doi:10.1101/gr.1293003. PMC 403697. PMID 12975309.
- Gerhard DS, Wagner L, Feingold EA, et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMC 528928. PMID 15489334.
- Suzuki-Inoue K, Fuller GL, García A, et al. (2006). "A novel Syk-dependent mechanism of platelet activation by the C-type lectin receptor CLEC-2". Blood. 107 (2): 542–9. doi:10.1182/blood-2005-05-1994. PMID 16174766. S2CID 168505.
- Rual JF, Venkatesan K, Hao T, et al. (2005). "Towards a proteome-scale map of the human protein-protein interaction network". Nature. 437 (7062): 1173–8. Bibcode:2005Natur.437.1173R. doi:10.1038/nature04209. PMID 16189514. S2CID 4427026.
- Watson AA, O'Callaghan CA (2006). "Crystallization and X-ray diffraction analysis of human CLEC-2". Acta Crystallographica Section F. 61 (Pt 12): 1094–6. doi:10.1107/S1744309105037991. PMC 1978148. PMID 16511244.
- Scherer SE, Muzny DM, Buhay CJ, et al. (2006). "The finished DNA sequence of human chromosome 12". Nature. 440 (7082): 346–51. Bibcode:2006Natur.440..346S. doi:10.1038/nature04569. PMID 16541075.
- Chaipan C, Soilleux EJ, Simpson P, et al. (2006). "DC-SIGN and CLEC-2 mediate human immunodeficiency virus type 1 capture by platelets". J. Virol. 80 (18): 8951–60. doi:10.1128/JVI.00136-06. PMC 1563896. PMID 16940507.
- Watson AA, Brown J, Harlos K, et al. (2007). "The crystal structure and mutational binding analysis of the extracellular domain of the platelet-activating receptor CLEC-2". J. Biol. Chem. 282 (5): 3165–72. doi:10.1074/jbc.M610383200. PMID 17132623.
- Suzuki-Inoue K, Kato Y, Inoue O, et al. (2007). "Involvement of the snake toxin receptor CLEC-2, in podoplanin-mediated platelet activation, by cancer cells". J. Biol. Chem. 282 (36): 25993–6001. doi:10.1074/jbc.M702327200. PMID 17616532.
- Watson AA, Eble JA, O'Callaghan CA (2008). "Crystal structure of rhodocytin, a ligand for the platelet-activating receptor CLEC-2". Protein Science. 17 (9): 1611–6. doi:10.1110/ps.035568.108. PMC 2525532. PMID 18583525.
PDB gallery | |
|---|---|
|
